60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.130
0.00 (0.00%)
At close: Aug 21, 2026, 4:00 PM EDT
1.114
-0.016 (-1.43%)
After-hours: Aug 21, 2026, 7:39 PM EDT

SXTP Revenue

60 Degrees Pharmaceuticals had revenue of $207.90K in the quarter ending June 30, 2026, a decrease of -32.47%. This brings the company's revenue in the last twelve months to $1.21M, up 23.41% year-over-year. In the year 2025, 60 Degrees Pharmaceuticals had annual revenue of $1.41M with 106.81% growth.

Revenue (ttm)
$1.21M
Revenue Growth
+23.41%
P/S Ratio
2.47
Revenue / Employee
$404,977
Employees
3
Market Cap
3.00M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.41M727.75K106.81%
Dec 31, 2024681.35K427.77K168.70%
Dec 31, 2023253.57K-257.64K-50.40%
Dec 31, 2022511.21K-5.84M-91.95%
Dec 31, 20216.35M3.80M149.18%
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
HCW Biologics6.72M
Curis4.31M
Onconetix645.82K
Virax Biolabs Group12.42K
Valion Bio-86.00K
Revenue Rankings